Status:
COMPLETED
3D MR Versus 3D CT for Glenohumeral Arthritis
Lead Sponsor:
NYU Langone Health
Conditions:
Arthritis
Glenohumeral Osteoarthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study aims to assess the efficacy of three-dimensional magnetic resonance (MR) compared to three-dimensional computed tomography (CT) imaging. This proposed study is a prospective, unrandomized, ...
Eligibility Criteria
Inclusion
- Patients suffering from glenohumeral OA;
- Radiographic evidence of severe glenoid erosion;
- Indication for TSA based on clinical exam;
- Patient is willing to participate by complying with pre-operative visit requirements;
- Patient is willing and able to review and sign a study informed consent form.
Exclusion
- Prior arthroplasty at the affected shoulder;
- Patients with inflammatory arthritis;
- Patients with post-capsulorrhaphy arthritis;
- Patients with post-traumatic arthritis;
- Patients with rotator cuff tear arthropathy;
- Patients exhibiting a lack of physical or mental ability to perform or comply with the study procedures;
- Patients who are pregnant;
- Patients with implanted medical devices that are contraindicated to exposure up to a 3.0-tesla magnetic field.
Key Trial Info
Start Date :
January 11 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 5 2020
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT03379545
Start Date
January 11 2017
End Date
June 5 2020
Last Update
March 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016